Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts

Luca Catalano; Sepideh Aminzadeh-Gohari; Daniela Weber; Rodolphe Poupardin; Victoria Stefan; William Smiles; Julia Tevini; René Feichtinger; S Derdak; M Bilban; S Bareswill; MM Heimesaat; Barbara Kofler

doi:10.3390/metabo13080910

Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts

Luca Catalano (First author)
, Sepideh Aminzadeh-Gohari (Co-author)
, Daniela Weber (Co-author)
, Rodolphe Poupardin (Co-author)
, Victoria Stefan (Co-author)
, William Smiles (Co-author)
, Julia Tevini (Co-author)
, René Feichtinger (Co-author)
, S Derdak
, M Bilban
, S Bareswill
, MM Heimesaat
, Barbara Kofler^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

9 Citations (Web of Science)

Original language	English
Pages (from-to)	910
Journal	METABOLITES
Volume	13
Issue number	8
DOIs	https://doi.org/10.3390/metabo13080910
Publication status	Published - 2023

Keywords

CANCER
INFLAMMATION
COMBINATION
METABOLISM
FGF21
MICE
ANTITUMOR
SURVIVAL
GLUCOSE

Access to Document

10.3390/metabo13080910

Cite this

Catalano, L., Aminzadeh-Gohari, S., Weber, D., Poupardin, R., Stefan, V., Smiles, W., Tevini, J., Feichtinger, R., Derdak, S., Bilban, M., Bareswill, S., Heimesaat, MM., & Kofler, B. (2023). Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts. METABOLITES, 13(8), 910. https://doi.org/10.3390/metabo13080910

@article{1b90ecb16d3a48ef83d48acd53da2430,

title = "Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts",

keywords = "CANCER, INFLAMMATION, COMBINATION, METABOLISM, FGF21, MICE, ANTITUMOR, SURVIVAL, GLUCOSE",

author = "Luca Catalano and Sepideh Aminzadeh-Gohari and Daniela Weber and Rodolphe Poupardin and Victoria Stefan and William Smiles and Julia Tevini and Ren{\'e} Feichtinger and S Derdak and M Bilban and S Bareswill and MM Heimesaat and Barbara Kofler",

note = "Catalano, Aminzadeh-Gohari, Weber, Stefan, Smiles, Tevini, Feichtinger, Kofler: Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria; Poupardin: Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Cell Therapy Institute, Paracelsus Medical University, 5020 Salzburg, Austria; ",

year = "2023",

doi = "10.3390/metabo13080910",

language = "English",

volume = "13",

pages = "910",

journal = "METABOLITES",

issn = "2218-1989",

publisher = "MDPI",

number = "8",

}

Catalano, L, Aminzadeh-Gohari, S, Weber, D , Poupardin, R , Stefan, V , Smiles, W , Tevini, J , Feichtinger, R, Derdak, S, Bilban, M, Bareswill, S, Heimesaat, MM & Kofler, B 2023, 'Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts', METABOLITES, vol. 13, no. 8, pp. 910. https://doi.org/10.3390/metabo13080910

Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts. / Catalano, Luca (First author); Aminzadeh-Gohari, Sepideh (Co-author); Weber, Daniela (Co-author) et al.
In: METABOLITES, Vol. 13, No. 8, 2023, p. 910.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts

AU - Catalano, Luca

AU - Aminzadeh-Gohari, Sepideh

AU - Weber, Daniela

AU - Poupardin, Rodolphe

AU - Stefan, Victoria

AU - Smiles, William

AU - Tevini, Julia

AU - Feichtinger, René

AU - Derdak, S

AU - Bilban, M

AU - Bareswill, S

AU - Heimesaat, MM

AU - Kofler, Barbara

N1 - Catalano, Aminzadeh-Gohari, Weber, Stefan, Smiles, Tevini, Feichtinger, Kofler: Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria; Poupardin: Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Cell Therapy Institute, Paracelsus Medical University, 5020 Salzburg, Austria;

PY - 2023

Y1 - 2023

KW - CANCER

KW - INFLAMMATION

KW - COMBINATION

KW - METABOLISM

KW - FGF21

KW - MICE

KW - ANTITUMOR

KW - SURVIVAL

KW - GLUCOSE

U2 - 10.3390/metabo13080910

DO - 10.3390/metabo13080910

M3 - Original Article

C2 - 37623854

SN - 2218-1989

VL - 13

SP - 910

JO - METABOLITES

JF - METABOLITES

IS - 8

ER -